You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. A Guideline Based Tool for Increasing Cancer Screening Rates

    SBC: BRIGHTOUTCOME INC.            Topic: N/A

    Breast, cervical, and colorectal cancer can be successfully prevented and or diagnosed and successfully treated at the earliest stages through the use of appropriate and timely screening as well as adequate followup and care coordination. Recognizing the importance of cancer screening, groups such as the American Cancer Society and the United States Preventative Services Task Force have developed ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Using Automated Abstractions to Classify System States for Software Health Monitoring

    SBC: Aries Design Automation, LLC            Topic: 9040477

    In most critical software systems, a state that is partially visible through values passed across interfaces contains information that could determine the health of the software system, and whether a failure is likely in the future. Some of this information behaves in a continuous fashion, e.g., the available memory or disk space is easily interpreted to monitor system health. Other values are nom ...

    SBIR Phase I 2011 Department of CommerceNational Institute of Standards and Technology
  3. A Versatile Microbot Fabrication Platform

    SBC: AMT Nano, LLC            Topic: 9050768R

    AMT Nano, LLC has developed innovative technology for achieving a versatile microrobot platform. The innovation relies on a unique micromolding process, which is low-cost and high-throughput, and high precison. The process achieves versatility by generating deterministic freeform shapes in polymers and nanocomposites. Several perceived benefits accompany the micromolding process. Due to the three- ...

    SBIR Phase I 2011 Department of CommerceNational Institute of Standards and Technology
  4. Development of a Scalable, Low-Cost, Ultrananocrystalline Diamond Electrochemical Process for the Destruction of Contaminants of Emerging Concern (CECs)

    SBC: Advanced Diamond TechNologies, Inc.            Topic: E

    This Small Business Innovation Research (SBIR) project will develop and ready for commercialization a scalable, low-cost process for purification of water containing Contaminants of Emerging Concern (CECs) using anodic oxidation with boron-doped ultrananocrystalline diamond (UNCD®) thin films. Resent research demonstrated that there is considerable potential for the development of electrochemica ...

    SBIR Phase I 2011 Environmental Protection Agency
  5. L-(+) Lactic Acid Production from Biodiesel Waste Using Pelletized Fungal Fermentation

    SBC: OMNILANE, INC.            Topic: H

    "With the rapid growth of biodiesel industry, the production of crude glycerol as one of major biodiesel byproducts has been dramatically increased. Fully utilizing such a large quantity of crude glycerol is critical to the sustainability of biodiesel industry. Lactic acid is an important industrial chemical that is widely used as a food additive for flavoring and preservative, a moistener in co ...

    SBIR Phase I 2011 Environmental Protection Agency
  6. A transfollicular nanovaccine against leishmaniasis

    SBC: VINDICO NANOBIOTECHNOLOGY, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the world. Annually, 2 million people are infected with Leishmania species and 270,000 will die. Leishmaniasis is one of the most important parasitic diseases affecting the U.S. military today, with over 2 ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Rapid Response Vaccines for Botulinum Neurotoxins

    SBC: Iterative Therapeutics Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNTs) are the most potent protein toxins known. Given their potent toxicity and their potential use in bio-warfare scenarios, BoNTs are included among the Category A select agents. The currentlyavailable pentavalent toxoid vaccine requires multiple boosters before being effective, and protects unequally against the different BoNT serotyp ...

    SBIR Phase I 2011 Department of Health and Human Services
  8. Apparatus and Method for Convection Enhanced Therapeutic Delivery

    SBC: FHC, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Malignancies of the brain are among the most devastating diseases known. Glioblastoma multiform (GBM) in particular are known for their rapid, uncontrolled, and aggressive growth. Very little progress has been made in the treatment of GBM over the past 25 years. A more recent promising therapeutic approach is convection enhanced delivery (CED) in which chemothe ...

    SBIR Phase I 2011 Department of Health and Human Services
  9. Modulation of In Vivo Tumor Oxygenation via Polymersome-encapsulated Myoglobin

    SBC: VINDICO NANOBIOTECHNOLOGY, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Over 250,000 new cases of head and neck cancers (HNCs) and non-small cell lung cancers (NSCLCs) are diagnosed every year in the United States. At the time of diagnosis, 60% of these cases are regionally advanced (stageIII and IV). Wide surgical excision is not the immediate therapeutic option for most of these locally advanced solid tumor malignancies. A number ...

    SBIR Phase I 2011 Department of Health and Human Services
  10. Multifunctional Peptides for (MRI) Imaging

    SBC: CDG THERAPEUTICS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Our overall goal is to expand the role of CPPs in molecular imaging at the patient level using large animal models of human tumors and a peptide agent that inherently provides 1) preferential access to a wide variety ofhuman solid (and hematologic) tumor cells, 2) an increased intracellular concentration (2-12 fold) over histologically matched normal cells, and ...

    SBIR Phase I 2011 Department of Health and Human Services
US Flag An Official Website of the United States Government